Kyocera AVX, a US-based subsidiary of Japan-based electronic components maker Kyocera, has committed to medical and deep technology-focused venture capital firm Good Growth Capital’s (GGC) second fund.
GGC has offices in both Charleston, South Carolina, and Boston, Massachusetts, to better target spinouts from its research universities.
Johnny Sarvis, CEO of Kyocera AVX, said: “This investment provides Kyocera AVX with abundant opportunities to further support the flourishing tech industry both here in the Carolinas and nationwide by investing through GGC and exploring co-investments, especially within segments of the med-tech industry that complement our existing R&D [research and development] programs within the Kyocera Group globally.”
“We are very hands-on in terms of helping our companies grow, and we see significant value in building a strong relationship with such a proven manufacturing partner,” added Amy Salzhauer, managing partner at GGC, which invests in seed stage and series A deals through the General Fund family and in pre-seed and seed stage companies through the Infinite Corridor Fund.
